Integra LifeSciences Holdings Corp. (NASDAQ:IART)
CAPS Rating:
The Company is dedicated to improving the quality of life for patients through the development, manufacturing and marketing of cost-effective surgical implants and medical instruments.
RSS Headlines
Fool UK
Recs
This company has been a consistent performer even through the past years misery. It looks good through $40 to $45 but then re-evaluate. I'm long term on this one and it is one of a few that keep me afloat.